The Cigna Group Q2 2025 Earnings Conference Call

Q2 2025 Financial Highlights

• 📈 The Cigna Group reported $67.2 billion in total revenue and $7.20 in adjusted earnings per share for Q2 2025.
• ✅ The company reaffirmed its full-year 2025 guidance of at least $29.60 adjusted EPS, demonstrating confidence in sustained performance.
• 💰 Over the last three, five, and ten years, Cigna has consistently achieved its growth algorithm of 10-14% compounded adjusted EPS growth.

Strategic Differentiators & Market Approach

• 💡 Cigna anticipates and creates constructive disruption, leveraging customer feedback to evolve and innovate, as seen with their "Commitment to Better" initiatives.
• 🧩 A diverse portfolio of businesses, including Evernorth and Cigna Healthcare, provides strategic flexibility and multiple avenues for growth.
• 🚀 The company's service-based, capital-light model allows for agility and nimbleness in a dynamic healthcare market.
• 🤝 Cigna proactively engages in public-private partnerships to address regulatory and legislative activity, such as streamlining prior authorizations with HHS.

Evernorth Segment Performance

• 📊 Evernorth now contributes over 60% of Cigna's enterprise earnings, reflecting sustained strength across its services.
• 📈 Specialty and Care Services saw strong growth, with revenue up 13% and adjusted earnings increasing 12%, driven by Accredo and biosimilar adoption.
• 💊 Pharmacy Benefit Services maintained strong client retention (mid-90s for 2026) and introduced innovative solutions like a GLP-1 benefit with a $200 monthly out-of-pocket cap.
• 🎯 Curiscript SD, a $25 billion business, is expanding services to health systems and providers, focusing on the medical benefit side of specialty pharmacy.

Cigna Healthcare & Market Trends

• 🏥 Cigna Healthcare's financial results were in line with expectations, despite persistently elevated medical costs, with a medical care ratio of 83.2%.
• 📈 The US employer business continues to grow, particularly in the select segment, through a consultative approach.
• ⚠️ The individual exchange business was strategically repositioned to prioritize margin over growth, leading to fewer customers but disciplined pricing actions.
• 📊 Cost trends remain elevated, particularly for specialty injectables and behavioral health services, influencing pricing assumptions for 2026.

Addressing Industry Challenges & Innovation

• 💲 Affordability is the top concern for employers, driving demand for integrated and innovative solutions to mitigate rising costs.
• ⚖️ Cigna is pleased with the temporary restraining order against Arkansas PBM legislation, arguing it would restrict access, choice, and increase costs.
• 🤖 New innovations include an AI-powered virtual assistant for Cigna Healthcare customers and continued development of GLP-1 programs to manage costs and access.
• 🤝 The competitive pricing environment is currently firm and rational, with Cigna expecting to secure higher price increases in 2026 compared to 2025.